December 05, 2016 10:45 PM ET


Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Cameron Durrant M.D., MBA58 RelationshipsChairman of the Board, Chief Executive Officer, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee56
David L. Tousley M.B.A., CPA11 RelationshipsInterim Chief Financial Officer60
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality61

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Cameron Durrant M.D., MBA 58 RelationshipsKaloBios Pharmaceuticals, Inc.56
James W. Larrick M.D., Ph.D. 39 RelationshipsKaloBios Pharmaceuticals, Inc.--
Ronald Barliant J.D. 5 RelationshipsKaloBios Pharmaceuticals, Inc.71
Timothy Morris 5 RelationshipsKaloBios Pharmaceuticals, Inc.54
Dale Chappell M.D. 5 RelationshipsBlack Horse Capital Advisors LLC46
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Timothy Morris5 Relationships3 Executives
Compensation Committee M.D., MBACameron Durrant58 Relationships2 Executives
Nominating Committee J.D.Ronald Barliant5 Relationships2 Executives
Corporate Governance Committee J.D.Ronald Barliant5 Relationships2 Executives
Advisory Board M.D., Ph.D.James W. Larrick39 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average


Calimmune Appoints Dr. Salim Yazji as EVP and Chief Medical Officer
November 26, 2016 8:27 AM ET
Vasopharm Names Irina Antonijevic as New Chief Medical Officer
November 25, 2016 12:28 PM ET
Alchemia Limited Announces Resignation of Nathan Drona as Non-Executive Director
November 24, 2016 10:15 PM ET
Shree Ganesh Bio-Tech (India) Limited Announces Management Changes
November 24, 2016 12:15 PM ET
Invitrocue Appoints Ramanuj Dasgupta as Senior Scientific Director, Effective December 1, 2016
November 23, 2016 10:53 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at